PATENT CLAIM ANALYSIS

Application Number: 15934403
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "136100"]

Abstract:
The present invention relates to methods for reducing or eliminating the non-specific release of a cytokine associated with a disease comprising administering at least one glucocorticoid and an immunostimulating antibody. Additionally, the present invention relates to a pharmaceutical composition that contains at least one immunostimulating antibody and at least one glucocorticoid.

Claim (Index 21):
A method of using a bispecific antibody for treating a cancerous disease in a subject, comprising:\n administering dexamethasone to the subject on the same day as and prior in time to beginning administration of the bispecific antibody, wherein the bispecific antibody is directed against tumor antigen CD19 and T-cell marker CD3.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14247029', '11977856', '12224010', '14600560', '14106737']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6759820964057814
- 35 USC 102 Novelty (BERT): 0.6531258998259072
- Combined Prediction Score: 0.673696476747794
- Mean Citation Score: 420.295972
- Max Citation Score: 707.0459599999997
- Similarity Product: 568.2762486462498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test